Document 1005
 DOCN  M9621005
 TI    Reducing HIV needle risk behaviors among injection-drug users in the
       Midwest: an evaluation of the efficacy of standard and enhanced
       interventions.
 DT    9602
 AU    Siegal HA; Falck RS; Carlson RG; Wang J; Wright State University, School
       of Medicine, Substance Abuse; Intervention Programs, Dayton, Ohio 45401,
       USA.
 SO    AIDS Educ Prev. 1995 Aug;7(4):308-19. Unique Identifier : AIDSLINE
       MED/96026585
 AB    This study compares the impact of a standard and an enhanced
       intervention on the needle-use behaviors reported by injection-drug
       users (IDUs) living in a low-seroprevalence area in the Midwest. Data on
       the drug- and needle-use practices of 381 IDUs completing a standard (n
       = 232) or an enhanced (n = 149) intervention who were followed-up five
       to nine months after a baseline interview were analyzed using bivariate
       and multivariate techniques. The results indicate that IDUs who
       participated in the enhanced intervention reported safer needle
       practices than standard intervention IDUs at follow-up. In addition,
       less frequent injectors were much more likely to adopt safer needle-use
       practices than were daily drug injectors, regardless of intervention
       track. The results suggest that more intensive interventions have
       advantages over minimalist efforts--in specific contexts. This finding
       has important implications for the HIV needle risk-reduction efforts
       targeting IDUs.
 DE    Adult  Behavior Therapy/METHODS  Comparative Study  Female  Health
       Education/*METHODS  Human  HIV Infections/*PREVENTION &
       CONTROL/TRANSMISSION  HIV Seroprevalence/TRENDS  *Knowledge, Attitudes,
       Practice  Male  Needle Sharing/*ADVERSE EFFECTS  Ohio/EPIDEMIOLOGY
       Program Evaluation  Psychotropic Drugs  Risk Factors  Street Drugs
       Support, U.S. Gov't, P.H.S.  Treatment Outcome  *Urban
       Population/STATISTICS & NUMER DATA  CLINICAL TRIAL  JOURNAL ARTICLE
       RANDOMIZED CONTROLLED TRIAL

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).